已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Utilization and Outcomes Associated With Intravascular Ultrasound during Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)

医学 血管内超声 危险系数 放射科 腔内修复术 腹主动脉瘤 主动脉瘤 动脉瘤 内科学 外科 心脏病学 置信区间
作者
Ramya Mosarla,Patrick Heindel,Mohamad A. Hussain,Marc L. Schermerhorn,Toshiki Kuno,Mario D’Oria,Siling Li,Eric A. Secemsky
出处
期刊:Circulation-cardiovascular Interventions [Ovid Technologies (Wolters Kluwer)]
标识
DOI:10.1161/circinterventions.124.014332
摘要

BACKGROUND: Intravascular ultrasound (IVUS) use in aortic endovascular interventions, including thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR), may have similar benefits to those seen in coronary and peripheral interventions, but limited utilization and outcome data exist. METHODS: Centers for Medicare and Medicaid Services claims data were used to identify patients undergoing TEVAR and EVAR from 2016 to 2023. Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death. Cox regression was used to estimate weighted hazard ratios. RESULTS: A total of 136 540 patients underwent TEVAR and EVAR, of which 9.8% (13 364) used IVUS. IVUS use increased slightly from 2016 to 2023, driven more by use in TEVAR compared with EVAR, and was higher in academic settings, with Medicare and Medicaid dual enrollment, in the West, with dissections, with malperfusion and for elective procedures. IVUS was associated with a lower risk of the primary outcome at 30-days (hazard ratio, 0.80 [95% CI, 0.73–0.89]; P <0.001) and 6-months (hazard ratio, 0.93 [95% CI, 0.87–0.99]; P =0.022) for all-comers. Subgroup analysis suggested lower risks of the primary outcome with IVUS use for aneurysm driven by the abdominal segment, malperfusion, thoracoabdominal dissection with malperfusion, thoracoabdominal repair, and chronic kidney disease. CONCLUSIONS: IVUS use has increased slightly in TEVAR and EVAR with heterogeneity in use. IVUS implementation during TEVAR and EVAR was associated with improved early and mid-term outcomes, particularly in certain subsets.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助端庄亦巧采纳,获得10
1秒前
Qingsic完成签到,获得积分10
1秒前
Ping完成签到,获得积分10
2秒前
wenhao完成签到 ,获得积分10
2秒前
2秒前
3秒前
bearvik完成签到,获得积分10
3秒前
打打应助许星意采纳,获得10
5秒前
嘿嘿完成签到 ,获得积分10
6秒前
7秒前
空空伊发布了新的文献求助10
7秒前
AaronW完成签到,获得积分10
9秒前
提拉米苏发布了新的文献求助30
11秒前
华仔应助高挑的板凳采纳,获得10
11秒前
祁连山的熊猫完成签到 ,获得积分0
11秒前
科研通AI6.1应助彼岸花开采纳,获得50
12秒前
科研通AI6.2应助Sue@00采纳,获得10
13秒前
哇咔咔完成签到 ,获得积分10
14秒前
hey754发布了新的文献求助10
14秒前
叫我益达完成签到,获得积分10
15秒前
仲夏夜之梦完成签到,获得积分10
15秒前
刘婉敏完成签到 ,获得积分10
16秒前
喵喵帮咩咩写论文完成签到 ,获得积分10
18秒前
咩呜关注了科研通微信公众号
19秒前
代秋发布了新的文献求助10
19秒前
淡淡的小松鼠完成签到,获得积分10
19秒前
21秒前
21秒前
耶耶完成签到,获得积分10
22秒前
kenti2023完成签到 ,获得积分0
23秒前
思源应助Costing采纳,获得10
23秒前
24秒前
温暖眼神完成签到,获得积分10
24秒前
打打应助淡淡的小松鼠采纳,获得10
25秒前
斯文败类应助zhangfan采纳,获得10
25秒前
小丸子完成签到 ,获得积分10
26秒前
jimmylafs发布了新的文献求助10
26秒前
27秒前
张子烜发布了新的文献求助10
27秒前
安心完成签到 ,获得积分10
28秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Eco-Evo-Devo: The Environmental Regulation of Development, Health, and Evolution 900
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
THC vs. the Best: Benchmarking Turmeric's Powerhouse against Leading Cosmetic Actives 500
培训师成长修炼实操手册(落地版) 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5926504
求助须知:如何正确求助?哪些是违规求助? 6955691
关于积分的说明 15831647
捐赠科研通 5054463
什么是DOI,文献DOI怎么找? 2719351
邀请新用户注册赠送积分活动 1674775
关于科研通互助平台的介绍 1608688